Sucralose artificial sweetener could make cancer treatment less effective

Sucralose is a popular sugar substitute for people who are cutting calories or managing blood sugar levels, but new research by the University of Pittsburgh and UPMC Hillman Cancer Center suggests that the artificial sweetener may not be the best choice for patients undergoing cancer immunotherapy.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup